In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

Published:2018-07-25 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Melagraki Georgia,Ntougkos Evangelos,Papadopoulou Dimitra,Rinotas Vagelis,Leonis Georgios,Douni Eleni,Afantitis Antreas,Kollias George

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference78 articles.

1. Suramin induces deoligomerization of human tumor necrosis factor alpha.;Alzani;J. Biol. Chem.,1993

2. Cellular mechanisms of TNF function in models of inflammation and autoimmunity.;Apostolaki;Curr. Dir. Autoimmun.,2010

3. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.;Arkin;Chem. Biol.,2014

4. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream.;Arkin;Nat. Rev. Drug Discov.,2004

5. Computer aided drug design: success and limitations.;Baig;Curr. Pharm. Des.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation;Angewandte Chemie International Edition;2024-02-26

2. Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation;Angewandte Chemie;2024-02-26

3. Aceclofenac/Citronellol Oil Nanoemulsion Repurposing Study: Formulation, In Vitro Characterization, and In Silico Evaluation of Their Antiproliferative and Pro-Apoptotic Activity against Melanoma Cell Line;Biomedicines;2023-09-14

4. Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors;International Journal of Molecular Sciences;2023-07-10

5. Mechanistic advances in osteoporosis and anti‐osteoporosis therapies;MedComm;2023-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3